Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).

被引：0
|
作者：
Chawla, Sant P.
Blay, Jean-Yves
Italiano, Antoine
Gutierrez, Martin
Le Cesne, Axel
Gomez-Roca, Carlos Alberto
Gouw, Launce G.
von Mehren, Margaret
Wagner, Andrew
Maki, Robert G.
Higgins, Brian
Middleton, Steven
Nichols, Gwen L.
Geho, David
Blotner, Steven
Zhi, Jianguo
Chen, Lin Chi
机构：
[1] Sarcoma Oncol Ctr, Santa Monica, CA USA
[2] Univ Lyon 1, Ctr Leon Berard, F-69365 Lyon, France
[3] Inst Bergonie, Bordeaux, France
[4] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[5] Inst Gustave Roussy, Villejuif, France
[6] Inst Claudius Regaud, Toulouse, France
[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
[10] Mt Sinai Sch Med, New York, NY USA
[11] Hoffmann La Roche Inc, Translat Clin Res Ctr, Oncol Translat Med Grp, Nutley, NJ 07110 USA
[12] Hoffmann La Roche Inc, Translat Clin Res Ctr, Nutley, NJ 07110 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of ET-743 in advanced soft-tissue sarcoma (ASTS) in adult: A STBSG-EORTC trial.
    Le Cesne, A
    Judson, I
    Radford, J
    Blay, JY
    Van Oosterom, A
    Rodenhuis, S
    Lorigan, P
    Di Paola, ED
    Jimeno, J
    Verweij, J
    ANNALS OF ONCOLOGY, 2000, 11 : 126 - 126
  • [22] Phase 1b Study Of The MDM2 Antagonist RG7112 In Combination With 2 Doses/Schedules Of Cytarabine
    Yee, Karen
    Martinelli, Giovanni
    Assouline, Sarit
    Kasner, Margaret
    Vey, Norbert
    Kelly, Kevin R.
    Drummond, Mark W.
    Dennis, Michael
    Seiter, Karen
    Blotner, Steven
    Jukofskyn, Lori
    Middleton, Steven
    Zhi, Jianguo
    Chen, Gong
    Zhong, Hua
    Nichols, Gwen
    BLOOD, 2013, 122 (21)
  • [23] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Chawla, Sant P.
    Staddon, Arthur
    Hendifar, Andrew
    Messam, Conrad A.
    Patwardhan, Rita
    Kamel, Yasser Mostafa
    BMC CANCER, 2013, 13
  • [24] Liposomal Doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas: A phase II study of the Italian Sarcoma Group (ISG)
    Toma, S
    Tucci, A
    Villani, G
    Carteni, G
    Spadini, N
    Palumbo, R
    ANTICANCER RESEARCH, 2000, 20 (1B) : 485 - 491
  • [25] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Sant P Chawla
    Arthur Staddon
    Andrew Hendifar
    Conrad A Messam
    Rita Patwardhan
    Yasser Yasser Mostafa Kamel
    BMC Cancer, 13
  • [26] Liposomal Doxorubicin in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma
    Di Filippo, F.
    Cavaliere, F.
    Anza, M.
    Garinei, R.
    Botti, C.
    Perri, P.
    Di Angelo, P.
    Patrizi, V.
    Di Filippo, S.
    Visca, P.
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 66 - 69
  • [27] Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.
    Broto, Javier Martin
    Marcilla, David
    Ramos, Rafael
    Moura, David Silva
    Alvarez, Ramiro
    Hernandez, Nieves
    Pujol, Carolina Agra
    Mayordomo, Empar
    Romagosa, Cleofe
    Bague, Silvia
    Reguero, Eugenia
    Cruz, Julia
    Martin, Francisco Javier
    Gutierrez, Antonio
    Cruz, Josefina
    Alvarez, Rosa Maria Alvarez
    Beveridge, Robert Diaz
    Morales, Claudia Maria Valverde
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Concomitant interleukin-2-doxorubicin (ADR) schedule in patients (PTS) with advanced soft tissue sarcomas (ASTS): A pharmacokinetic study
    LeCesne, A
    Vassal, G
    Farace, F
    Spielmann, M
    LeChevalier, T
    Tursz, T
    Escudier, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 586 - 586
  • [29] Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma
    Blay, Jean-Yves
    von Mehren, Margaret
    Samuels, Brian L.
    Fanucchi, Michael P.
    Ray-Coquard, Isabelle
    Buckley, Brigid
    Gilles, Leen
    Lebedinsk, Claudia
    Elsayed, Yusri A.
    Le Cesne, Axel
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6656 - 6662
  • [30] Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group
    Woll, PJ
    Judson, I
    Lee, SM
    Rodenhuis, S
    Nielsen, OS
    Buesa, JM
    Lorigan, PC
    Leyvraz, S
    Hermans, C
    van Glabbeke, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) : 410 - 412
12345